News Index March
Ranbaxy expands its European reach
Ranbaxy Laboratories, India's biggest drug maker, said Wednesday
that it would buy Terapia of Romania for $324 million to increase
sales of generic medicines in Europe...
Read Full News...
Sanofi invests in generics
market
BUDAPEST Sanofi-Aventis bought a 24.9 percent stake in the Czech
drug maker Zentiva for €430 million, the French company said
Monday, as it expands in Russia and Eastern Europe and positions
itself for growth in the market for generic drugs...
Read Full News...
Consumers: Nomisma Report
on Generic Drugs
Sales for generic drug equivalents - especially type C, non-prescription
drugs - rose steeply last year, accounting for 25.5 pc of total
drugs sales...
Read Full News...
Russia changes DLO programme
rules - How will it affect Richter and Egis?
Russia's Health Minister Mikhail Zurabov has signed a decree changing
the rules for the DLO Programme, under which the distribution of
DLO drugs is to occur by name of active ingredients or INN (International
Nonproprietary Name) rather than brand name, Citigroup analyst,
Robert Bonte-Friedheim said in an analysis...
Read Full News...
FDA chief says unique generics
get priority
The U.S. Food and Drug Administration is taking steps to eliminate
a backlog of more than 800 pending generic drug applications by
focusing on those offering the first cheaper alternative therapy,
the agency's acting chief told Congress on Tuesday..
Read Full News...
Watson Pharmaceuticals to
Acquire Andrx for $1.9 Bln (Update4)
Watson Pharmaceuticals Inc. said it will acquire Andrx Corp. for
$1.9 billion to become the third- largest maker of generic drugs
in the U.S. Read Full News...
Glaxo Loses U.S. Court Bid
to Stop Generic Flonase
GlaxoSmithKline Plc has lost its legal attempt to prevent the launch
of generic versions of its allergy nasal spray, Flonase, in the
United States, Europe's biggest drug maker said on Tuesday.
Read Full News...
|
